Man and woman looking at computer in Insurance Brokerage

Press Centre

  • 14 May 2018

    Manchester branch raises thousands for local charity Alex Hulme Foundation

    Gallagher team members in Manchester have raised over £12,000 in the space of one year for local charity Alex Hulme Foundation, with every penny helping to fund a clinical research project that will ultimately result in improved cancer treatment for children over the years to come. The team's latest donation of £12,396 forms part of an ongoing fundraising programme, which will see the broker continue its support throughout 2018.

    Alex Hulme cheque presentation 2018
  • 9 May 2018

    Gallagher acquires Chester-based regional insurance broker Risk Services

    Gallagher today announces the acquisition of regional commercial insurance broker Risk Services (NW) Ltd (‘Risk Services’) based in Chester. Terms of the transaction were not disclosed.

    Hand signing paper
  • 30 April 2018

    How can Cyber insurance help you prepare for GDPR?

    GDPR (General Data Protection Regulation) is undoubtedly the hot topic in insurance at the moment and with its introduction in May imminent this is unlikely to change. While the majority of businesses are preparing for GDPR in various ways, few have looked at cyber insurance as a way of helping them to meet their obligations. In this bulletin Gallagher discuss how cyber insurance can do this.

    How can Cyber insurance help you prepare for GDPR
  • 30 April 2018

    Don’t get caught out by Counterfeit Plant Equipment

    Increased activity in the construction market brings with it the demand for additional plant and equipment. Whilst secondhand plant or equipment is often a cost effective solution, and the genuine articles are not sub-standard, purchasing ‘used’ equipment runs the risk of it being potentially counterfeit equipment.

    Dont get caught out by Counterfeit Plant Equipment
  • 24 April 2018

    Life Sciences - Intellectual Property Insurance

    This type of insurance is often overlooked by companies in the Life Science sector despite their Intellectual Property (IP) being a considerably valuable asset.

    Life Sciences
Print Page